The association of new-onset diabetes with subsequent diagnosis of pancreatic cancer—novel use of a large administrative database
Journal of Public Health · 2023
DOI: 10.1093/pubmed/fdac118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Public Health, 2023. Verfasst von M J White und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Minnesota, Minneapolis MN, 55455 USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Screening options for pancreatic ductal adenocarcinoma (PDAC) are limited. New-onset type 2 diabetes (NoD) is associated with subsequent diagnosis of PDAC in observational studies and may afford an opportunity for PDAC screening. We evaluated this association using a large administrative database.
Methods
Patients were identified using claims data from the OptumLabs® Data Warehouse. Adult patients with NoD diagnosis were matched 1:3 with patients without NoD using age, sex and chronic obstructive pulmonary disease (COPD) status. The event of PDAC diagnosis was compared between cohorts using the Kaplan–Meier method. Factors associated with PDAC diagnosis were evaluated with Cox’s proportional hazards modeling.
Results
We identified 640 421 patients with NoD and included 1 921 263 controls. At 3 years, significantly more PDAC events were identified in the NoD group vs control group (579 vs 505; P < 0.001). When controlling for patient factors, NoD was significantly associated with elevated risk of PDAC (HR 3.474, 95% CI 3.082–3.920, P < 0.001). Other factors significantly associated with PDAC diagnosis were increasing age, increasing age among Black patients, and COPD diagnosis (P ≤ 0.05).
Conclusions
NoD was independently associated with subsequent diagnosis of PDAC within 3 years. Future studies should evaluate the feasibility and benefit of PDAC screening in patients with NoD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, University of Minnesota, Minneapolis MN, 55455 USA.
- OptumLabs® Visiting Fellow, Eden Prairie, MN, USA Institute for Health Informatics, University of Minnesota, Minneapolis MN, 55455 USA.
- Masonic Cancer Center, University of Minnesota, Minneapolis MN 55455, USA.
- Clinical and Translational Science Institute, University of Minnesota, Minneapolis MN, 55455 USA.
- Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa FL 33612 USA.
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
White, M. J., Sheka, A. C., LaRocca, C. J., Irey, R. L., Ma, S., Wirth, K. M., Benner, A., Denbo, J. W., Jensen, E. H., Ankeny, J. S., Ikramuddin, S., Tuttle, T. M., Hui, J. Y. C., & Marmor, S. (2023). The association of new-onset diabetes with subsequent diagnosis of pancreatic cancer—novel use of a large administrative database. Journal of Public Health. https://doi.org/10.1093/pubmed/fdac118
Vancouver
White MJ, Sheka AC, LaRocca CJ, Irey RL, Ma S, Wirth KM, et al. The association of new-onset diabetes with subsequent diagnosis of pancreatic cancer—novel use of a large administrative database. Journal of Public Health. 2023. doi:10.1093/pubmed/fdac118
BibTeX
@article{White2023,
author = {White, M J and Sheka, A C and LaRocca, C J and Irey, R L and Ma, S and Wirth, K M and Benner, A and Denbo, J W and Jensen, E H and Ankeny, J S and Ikramuddin, S and Tuttle, T M and Hui, J Y C and Marmor, S},
title = {The association of new-onset diabetes with subsequent diagnosis of pancreatic cancer—novel use of a large administrative database},
journal = {Journal of Public Health},
year = {2023},
doi = {10.1093/pubmed/fdac118}
}
EUVIMED